Cerberus Weighs Sale of $800 Million Drugmaker Covis

(Bloomberg) -- U.S. buyout firm Cerberus Capital Management is considering a sale of its closely-held drugmaker Covis Pharma Holdings Sarl that could fetch about $800 million, according to people f...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.